SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is seeing heightened community attention following a potential positive shift in China export conditions, with investors weighing this news against ongoing broader market volatility. While some discuss the stock's long-term valuation and fundamental strength as an AI leader, others remain focused on technical resistance levels and short-term price swings driven by geopolitical headlines.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is trending as investors react to a significant NASA lunar lander contract, sparking heavy debate over whether the stock's recent volatility is driven by institutional manipulation or long-term potential. While bulls point to strong analyst sentiment and contract wins, community discourse remains polarized by concerns over share dilution, the impact of index removals, and active short-selling pressure.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is seeing significant price volatility and heavy trading volume as investors react to its role in the critical AI data center power infrastructure buildout. The community is actively debating the stock's long-term potential as a 'bottleneck' play for hyperscalers, with sentiment split between bullish views on its massive energy-to-AI partnerships and skeptical voices questioning the company's valuation and volatility.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is gaining significant traction following a massive multi-year partnership with Apple to develop and produce custom U.S.-made chips, a move investors view as a major long-term catalyst for revenue growth. The community remains highly focused on Broadcom's pivotal role in AI infrastructure, with active debate centered on whether recent pullbacks provide a prime buying opportunity for this long-term backbone of data center connectivity.

Penguin Solutions, Inc. engages in designing, building, and managing enterprise solutions. It operates through the following segments: Advanced Computing, Integrated Memory, and Optimized LED. The Advanced Computing segment offers platform solutions and services for artificial intelligence, high-performance computing, machine learning, advanced modeling, and the internet of things. The Integrated Memory refers to integrated memory solutions through the design and development. The Optimized LED segment comprises a broad portfolio of application-optimized LEDs. The company was founded in 1988 and is headquartered in Fremont, CA.

Penguin Solutions Inc.

Penguin Solutions ($PENG) is experiencing intense momentum as it establishes itself as a core player in the AI infrastructure and memory management sectors. The stock is drawing massive interest from traders who are closely following its partnership with NVIDIA, strong quarterly earnings, and the company's critical role in meeting the surging demand for AI factory capacity.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending as investors monitor the company's strategic push to accelerate the Tanbreez rare earth project, with the community actively discussing potential institutional interest and the stock's role in Western supply chain security. Despite this long-term thesis, retail sentiment is polarized, characterized by frustration over recent price stagnation and skepticism toward management's communication, while many remain focused on the company's valuation relative to the project's massive mineral potential.

Direxion Shares ETF Trust - Direxion Daily MSCI South Korea Bull 3X ETF

Direxion Daily South Korea Bull 3X Shares

KORU is currently experiencing extreme volatility driven by technical rebalancing of South Korean pension fund holdings and speculative trading surrounding upcoming semiconductor IPOs and stock splits. Investors are intensely debating whether the dramatic price swings are a signal of a larger market correction or merely a temporary, liquidity-driven discount opportunity within the AI-fueled memory chip sector.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals is seeing intense investor interest and elevated trading volume as the stock hits new 52-week highs, driven by speculation surrounding a potential buyout and recent strategic moves to streamline operations. The community is actively discussing the stock's significant short interest and favorable technical momentum, with many investors debating whether this price action signals an imminent acquisition or a sustained move toward higher valuations.

Arista Networks, Inc. engages in the development, marketing, and sale of cloud networking solutions. Its solutions include EOS, a set of network applications, and Gigabit Ethernet switching and routing platforms. Its product categories include Core, Cognitive Adjacencies, and Network Software and Services. The company was founded by Andreas Bechtolsheim, David Cheriton, and Kenneth Duda in November 2004 and is headquartered in Santa Clara, CA.

Arista Networks Inc

Arista Networks is currently trending as investors debate the impact of AI infrastructure supply chain constraints despite a strong fundamental performance and significant institutional interest. The community is actively discussing potential entry points and accumulation strategies, viewing the stock as a critical 'picks-and-shovels' play in the broader AI networking buildout.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The SPY is experiencing heightened volatility and intense community debate as investors navigate a complex mix of geopolitical tensions in the Middle East and anticipation regarding upcoming Federal Reserve policy minutes. Traders are actively clashing over the market's resilience, with many pointing to aggressive algorithmic buying patterns and Trump-related commentary as catalysts for ongoing intraday swings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$IVVD Bottom line, nobody other than Insiders have any clue where this is headed. We can all assume but trust me they&#39;ve conversations with the folks that make the final decisions and have a fairly clear path of what&#39;s going to happen one way or the other. We remain pawns in this game.  Anybody have access as to latest buying or selling by large institutions? (Most likely data is to old to matter at this stage) 
 
What&#39;s everyone&#39;s thought at this stage? I&#39;d like to hear good and bad. I know many just look at this as a COVID company and that may be it&#39;s nearest headwind but it&#39;s more than that and I just don&#39;t see all this angel investor money losing. They know the answer.  Yes, I get COVID is dead but hell in my mind it&#39;s just a stronger case of the flu but they still sell millions of flu shots seasonally so that doesn&#39;t change. 
 
Again thoughts. (May be away for a couple of days) Is $10 out of the realm? I felt $7-$10 was a solid range and a bit higher on a buyout. 
Thoughts?

Casioleez

BallKnowerR

Tolib Nutfulloev

StockTwits Web

Invivyd Inc

 Bottom line, nobody other than Insiders have any clue where this is headed. We can all assume but trust me they've conversations with the folks that make the final decisions and have a fairly clear path of what's going to happen one way or the other. We remain pawns in this game.  Anybody have access as to latest buying or selling by large institutions? (Most likely data is to old to matter at this stage) 
 
What's everyone's thought at this stage? I'd like to hear good and bad. I know many just look at this as a COVID company and that may be it's nearest headwind but it's more than that and I just don't see all this angel investor money losing. They know the answer.  Yes, I get COVID is dead but hell in my mind it's just a stronger case of the flu but they still sell millions of flu shots seasonally so that doesn't change. 
 
Again thoughts. (May be away for a couple of days) Is $10 out of the realm? I felt $7-$10 was a solid range and a bit higher on a buyout. 
Thoughts?

billsmall

@billsmall unlikley to get full approval for pemgarda --COB just word salading at this point--covid is now emdemic and largely benign.  new oral agent for treatment  recently approved.  2311 is predicated on same immunobridging as pemgarda......

 unlikley to get full approval for pemgarda --COB just word salading at this point--covid is now emdemic and largely benign.  new oral agent for treatment  recently approved.  2311 is predicated on same immunobridging as pemgarda......

Bronwyn

@billsmall I’m not worried about it since IVVD is well positioned to submit the BLA for full approval of 2311 by EOY. However, I will keep an eye on any delays since they are cutting close to their deadline.

 BLA on a shorter horizon - VYD2311 for COVID prevention

VYD2311 for Long COVID - This is actually the next fastest opportunity because it&#39;s the same molecule.

There are advantages:
- Existing manufacturing.
- Existing toxicology package.
- Existing pharmacokinetic data.
- Existing safety database.
However, efficacy in Long COVID still has to be demonstrated, so it cannot &quot;piggyback&quot; directly on the prevention BLA.

Everything else in their pipeline is a few if not several years away.

StockTwits for iOS

 I’m not worried about it since IVVD is well positioned to submit the BLA for full approval of 2311 by EOY. However, I will keep an eye on any delays since they are cutting close to their deadline.

 BLA on a shorter horizon - VYD2311 for COVID prevention

VYD2311 for Long COVID - This is actually the next fastest opportunity because it's the same molecule.

There are advantages:
- Existing manufacturing.
- Existing toxicology package.
- Existing pharmacokinetic data.
- Existing safety database.
However, efficacy in Long COVID still has to be demonstrated, so it cannot "piggyback" directly on the prevention BLA.

Everything else in their pipeline is a few if not several years away.